Condition
Macula Hole
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05287269Completed
Ocular Coherence Tomography During Cataract Assessment
NCT04859556Not ApplicableCompleted
Performance, Safety and Efficiency Comparison Between 10,000 and 5,000 Cuts Per Minute Vitrectomy Using a 25G Cutter - A Prospective Randomized Controlled Study
NCT03528122Not ApplicableUnknownPrimary
Amniotic Membrane for Recurrent Macular Hole
NCT03287102Not ApplicableUnknownPrimary
Macular Hole Surgery With Temporal Inverted Internal Limiting Membrane Flap (MARTIAL)
NCT01162356Completed
Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study
Showing all 5 trials